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Abstract 
A human lung simulator was implemented using a 
model based on the Fick principle. The simulator is 
designed to emulate C02 production and 0 2 consumption 
in the body and gas exchange in the lung. The 
implementation consists of hardware and software to 
control the flow of gases entering and leaving a ventilated 
test lung. An initial test of C02 production qualitatively 
demonstrated that the lung simulator behaved as expected. 
Since this project is in its initial stages, additional 
experimentation and model refinement is necessary for the 
simulator to accurately represent physiologic responses of 
a human lung. 
Introduction 
Modeling and simulation are important means of 
testing and validating new medical devices without 
involving live subjects. Human and animal testing is 
expensive. Furthermore, control of respiratory parameters 
may be difficult or impossible to obtain during an 
experiment on live subjects. Creating a model and a 
simulation may provide the means to validate new 
instrumentation with less cost and more accuracy. 
With this in mind, we have created a human lung simulator 
to validate prototype anesthesia instrumentation. Our 
simulator is designed to model C02 production and 0 2 
consumption, given a value for cardiac output. Such a 
simulator may be used to validate medical devices that 
measure cardiac output non-invasively. 
C02 production and 0 1 consumption 
Figure 1 shows a simple representation of blood flow 
and gas exchange in the body. Oxygen is inspired into the 
alveoli of the lungs where it diffuses across the alveolar 
membrane and pulmonary capillary membrane. Likewise, 
carbon dioxide diffuses from the blood in the pulmonary 
capillary beds and into the alveoli. Oxygen rich blood is 
pumped through the right heart and into the tissues where 
metabolism consumes oxygen and produces carbon 
dioxide. Thus, C02 rich blood is pumped through the left 
side of the heart and back into the lungs 1• 
Cardiac output is related to gas exchange using a mass 
1 
balance equation, also known as the Fick principle2: 
(1) 
where Q is cardiac output (liters/minute), vco1 produced is 
the amount of C02 produced by tissue metabolism, 
(liters/minute), cv is the mixed venous C02 C02 
concentration of the blood (blood flowing into lungs in% 
volume) and c a is the arterial C02 concentration of C02 
blood flowing from the lungs(% volume). For our lung 
simulator, we set the cardiac output to a known value. 
Thus, we may rearrange (1) so that, 
Vco produced = Q · ( Cv - C a ). (2) 
2 C02 C02 
For every unit of C02 produced in the tissues, there is 
some amount of 02 consumed (Vol consumed ). C02 
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Figure 1: Gas Exchange and Blood Flow in the 
Human Lung and Body. 
production may be related to 0 2 consumption by the 
respiratory exchange ratio, R, where 
v. R = .C02 produced 
v 
02 consumed 
(3) 
R is a function of metabolism; the body oxidizes fats, 
carbohydrates, and proteins, where Rrar. = 0.7, Rcarbohydrate = 
1.0, and~= 0.8. For a healthy human, a typical value 
for R is 0.8.2 
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Figure 2: Physical Components of the Lung 
Simulator 
2 
Lung Simulator Implementation 
We use equations (2) and (3) as the foundation 
for our lung simulator. The physical components of the 
simulator are shown in Figure 2. Since the largest portion 
of ambient air is composed ofN2, 0 2, and C02, we use 
three mass flow controllers (MFCs) to regulate the flow of 
these gases from pressurized tanks into a ventilated 
test/training lung (TIL). A fan inside the TIL provides 
active mixing of the gases from the lung simulator and the 
ventilator. A vacuum is used to pull the mixed gas from 
the TIL in which the flow is regulated by the exhaust 
MFC. 0 2 and C02 sensors, located in the exhaust flow, 
record the concentrations of oxygen and carbon dioxide in 
the lung. A microprocessor controls the flow of the MFCs 
and receives input from the C02 and 0 2 sensors. A 
personal computer communicates with the microprocessor 
and provides the user with an interface to input cardiac 
output and cv (see Figure 3). 
COl 
02MFC 
Exhaust 
MFC 
Computer and 
User Interface 
Figure 3: Microprocessor Control and 
Communication 
The lung simulator uses the 0 2 and C02 sensors to 
calculate the flow of oxygen (V02 ) and carbon dioxide 
(Vco
2 
) pulled from the lung by the vacuum. The exhaust 
flow (V Exh ) is set at a constant rate, so 
(4) 
and 
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where F02 and Fc02 is the fraction of 0 2 and C02 
measured by the sensors in the exhaust flow. Also, 
(5) 
and we may solve for N2 flow going into and coming out 
from the lung: 
In order to calculate 0 2 consumption and C02 
production, we assume that the content of C02 in the 
mixed venous blood, C- , is constant. To compute Vco2 
c , we first find P , arterial partial pressure (mm 
aco2 aco2 
Hg), which is a function of barometric pressure, Phar (mm 
Hg). So, 
P = Fco · ~ar (mm Hg). (8) aco2 2 
P is related to c by a dissociation curve. Such a 
aco2 aco2 
curve is empirically derived by Capek and Roy,3 which 
also requires the hemoglobin (Hb) content of blood in 
grams per deciliter. So, 
Ca (Pa ) = (6.957 · Hb + 94.864) · (
9
) 
C<l2 C02 (val%). 
ln(1+0.1933·Pa ) 
C02 
This function is plotted in Figure 4. 
Using equations (2) -- (9), we may define the flow of 
gas into the lung, V Total In : 
C~MFCFJow 
. [• . J V Total1n = V C02 + V C02Produced + 
0 2 MFCF/ow N2 MFCF/ow ,............ 
. 
Also, (1 0) computes the quantity of flow for each gas 
coming into the lung, which is set by its corresponding 
MFC as demonstrated in Figure 2. 
(10) 
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Figure 4 : C02 Dissociation Curve With 
Hb = 15 g/dl 
Validation of Lung Simulator 
Since this project is a work in progress, we have only 
begun to validate the simulator. At this time, we have 
compared C02 production in the lung simulator to 
measured C02 production on an anesthesia monitor. This 
was achieved by comparing Vco produced , and Pa of the 
2 C02 
lung simulator to C02 excretion at the mouth ( Vco2 mouth , 
Vmin) and end tidal C02 (etC02, mm Hg) by the 
anesthesia monitor. Our TIL may be considered as a 
single alveolus with 100% perfusion (no parallel 
deadspace ). Under these conditions, alveolar partial 
pressure of C02 ( P 4 ) is approximately equal to Pa . 
''m2 C02 
P 4 is related to etC02 by: 
£.0"02 
etC02 = r. p Aco2 peifused + (1- r)P Aco2 unpeifused' (II) 
where r is the ratio of perfused to unperfused alveoli.4 A 
single alveolus model with no dead space yields 
etC02 = PL ~ pa . (12) 
"'C02 C02 
In addition, under steady state, vco2 mouth should also have 
similar values to vco2 produced • 
To validate the parameters described in the previous 
section, we induced changes in the Vco produced and Pa 
2 C02 
by changing the set value of cardiac output. For this 
validation experiment, we decreased cardiac output in one 
liter/min steps from 6.0 liters/min to 1.0 liter/min. Table I 
describes the times at which cardiac output was altered. 
Ample time was allowed between each step change so that 
the system may reach steady state. Figures 5 and 6 show 
comparisons of Pa to etC02 and Vco produced to 
"''2 2 
VC02 mouth respectively. Unfortunately, these plots should 
cardiac Output (liters/min) Approx.lime (seconds) 
6.0 1830 
5.0 2100 
4.0 2400 
3.0 2690 
2.0 2960 
1.0 3280 
Table 1: Step Decrease in Cardiac Output 
be investigated qualitatively because there is a mismatch in 
the synchronization of the data collection times. There is 
some inherent delay between the response of the etC02 
signal to a change in alveolar pressure, but it is not on the 
order of hundreds of seconds. 
2000 2500 3000 3500 
time (seconds) 
Figure 5: Arterial C02 (gray "0") and etC02 
(black"+") 
It is apparent from Figure 5 that both signals show a 
decreasing step change that corresponds to the change in 
cardiac output. The etC02 is shifted up from the Pa date 
COl 
approximately 3 to 4 mm Hg. The synchronization error is 
also apparent for the C02 production values demonstrated 
4 
in Figure 6. 
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Figure 6: C02 Production in the Lung Simulator 
(lung = gray "0", mouth =black "+'7,the numbers 
in the plot represent the value of cardiac output at 
that time 
Discussion 
3500 
Due to the limited amount data collected for validation 
of the lung simulator and difficulties with synchronization 
of the data collected, no significant conclusions may be 
made about the accuracy of the lung simulator at this time. 
It is important to note that this test described in the 
previous section does not match the physiologic response 
of a human's lung. That is, even though there was a fall in 
the C02 parameters for the given cardiac output values, 
they may not correspond correctly for a human response. 
Additional experiments using human data and comparing it 
to the lung simulator data are necessary in order to evaluate 
how well the lung simulator models the human respiratory 
system. The initial validation tests look promising with 
respect to the expected behavior of the lung simulator. All 
C02 parameters fell in accordance with a decreasing step 
change in cardiac output. 
The upward shift in etC02 (Figure 5) may be due to 
different computation methods for the lung simulator and 
the anesthesia monitor. For instance, the dissociation curve 
that is implemented for the simulator is based on empirical 
data and may not match the computation methods used by 
the monitor. Examination of the anesthesia monitor's 
specifications could give insight into how etC02 is 
calculated. 
Ignoring the effects of the shifted data, there are some 
transient spikes for the lung simulator's C02 production 
(see Figure 6). The spikes are due to step changes in 
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cardiac output. The step change in cardiac output causes 
an instantaneous change in Vco
1 
produced • As 
Pa decreases in response to the change, the C02 
coz 
production rises to a value comparable with the C02 
excreted at the mouth. 
Future Development 
While the hardware of the lung simulator requires 
little additional adjustment, there are many enhancements 
that still require implementation. As previously stated, 
more experimentation is required to determine the 
performance of the lung simulator. For instance, we have 
yet to validate whether 0 2 consumption in our simulator 
corresponds to the values computed by an 0 2 metabolic gas 
monitor. In addition, experiments that induce rapid 
changes in cardiac output, hypoxia, and hypercapnia are 
necessary to determine lung simulator performance. 
The current model is based on the Fick principle, 
which assumes a system in steady state. Thus, the model 
may yield unpredictable results to the transient responses. 
Furthermore Cv- is required to be constant in order to 
coz 
solve for Vc01 in the Fick equation. This assumption is 
normally valid since there is a large buffering capacity for 
C02 in the body, especially in fat and muscle.5• 6 On the 
other hand, it may not be a valid assumption for patients in 
septic shock, where most of the blood is flowing to vital 
organs in which do not store large quantities ofC02•6• 7 
Finally it is important to notice that the Fick equation does 
not account for shunt, blood that bypasses the gas 
exchange occurring in the ventilated alveoli of the lung. 
Therefore, the Fick equation provides an accurate estimate 
of cardiac output if shunted blood is not present. Othetwise 
it measures pulmonary-capillary blood flow. 
A more sophisticated model may help to account for 
these assumptions. Chiari, Avanzolini, and Ursino have 
proposed a sophisticated respiratory model that simulates 
the transport of gases to several different compartments 
including the brain, cerebral spinal fluid, tissues and the 
lungs. It also accounts for shunt, has chemoreceptor 
control for ventilation, and incorporates acid/base 
regulation into its C02 dissociation curve8• Such a 
sophisticated model may be incorporated into our lung 
simulator to improve the accuracy of the model with 
respect to human respiratory system. 
5 
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